Check-Cap Ltd. - Ordinary Share (MBAI)
Healthcare › X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Price History
Feb 9, 2026 — May 11, 2026Investment Snapshot
- Trading 33% below Graham Number ($2.17) — significant margin of safety
- Piotroski F-Score 2/9 — signs of financial weakness
- Loss-making — negative ROE of -84.5%
Check-Cap Ltd. - Ordinary Share (MBAI) is a Healthcare company operating in X-Ray Apparatus & Tubes & Related Irradiation Apparatus, listed on the NASDAQ , with a market capitalisation of $10 million . Key value metrics: P/E ratio 2.5, Piotroski F-Score 2 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Check-Cap Ltd. - Ordinary Share — Fundamental Analysis Summary
Check-Cap Ltd. - Ordinary Share (MBAI) is trading 33% below its Graham Number of $2.17 — a significant margin of safety by Benjamin Graham's standard. The stock carries a low trailing P/E ratio of 2.5x.
On financial health, MBAI shows a weak Piotroski F-Score of 2/9, a signal of deteriorating financial health, and negative return on equity of -84.5% (sector average: -20.6%).
StockPik's composite Value Score for MBAI is 50/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
MBAI shows earnings growing at 116%.